CCL2 and Sepsis: All of these findings suggest that propofol can serve as an effective therapeutic medication to suppress sepsis-induced renal injury in vivo and in vitro by activating miR-290-5p and the subsequent inhibiting CCL-2 and its downstream pathways, such as the inflammatory response.